Baylor College of Medicine Investigates Professor Over Avandia Article

Justin Sullivan, Getty Images

The diabetes drug Avandia was praised in a 2001 journal article that appears to have been ghostwritten by the manufacturer.
July 16, 2010 Premium content for subscribers. Subscribe Today

One day after a federal advisory panel expressed safety concerns about GlaxoSmithKline's diabetes drug Avandia, the Baylor College of Medicine said on Thursday that it is considering whether to penalize an assistant professor who apparently allowed...

This content is available exclusively to Chronicle subscribers